Congenital Melanocytic Naevus (CMN) is a rare genetic skin condition that appears at birth, manifesting as pigmented marks that vary significantly in size and severity. These marks can cover small areas or, in extreme cases, up to 80% of the body. For some, CMN remains a dermatological concern, but for others, it poses neurological complications and a heightened risk for melanoma. The lived experiences of families affected by CMN reflect a common journey marked by uncertainty and the desire for understanding from healthcare professionals.
One of the authors, Jodi, experienced the challenges of CMN firsthand, undergoing over 30 surgical procedures during her childhood. Limited knowledge among healthcare providers at that time often led to inadequate care and interventions based on fear rather than established evidence. The moment she was diagnosed at 16 transformed her experience; having a name identified her condition and offered a sense of connection to a broader community facing similar challenges.
The psychosocial implications of rare diseases like CMN are profound. Individuals with visible conditions often face scrutiny and misunderstanding, which can lead to isolation. Both authors recount their experiences—from Jodi's perspective as a patient to Gemma's as an advocate—and discuss how early medical interventions often emphasized their differences before allowing them to establish their identities. This leads to detrimental effects on confidence and well-being that are frequently absent from clinical evaluations.
The impact of community cannot be overstated; personal connections among individuals with CMN foster a supportive environment that can alleviate feelings of isolation. Jodi recalls the significant shift that occurred when she connected with other families affected by CMN, showing that mutual support creates a sense of belonging and facilitates shared experiences that are vital for emotional health.
In 2019, the exhibition “HOW DO YOU C ME NOW?” was launched by Caring Matters Now to shift societal perceptions of visible differences. The event reached thousands of visitors and featured stories and photographs that highlighted the diversity and strength of individuals living with CMN. Participants reported increased confidence and empowerment after sharing their narratives publicly, showcasing the transformative power of visibility and understanding.
When seen through a compassionate lens, differences become less defining and more about shared humanity, bridging gaps in understanding and appreciation.
The partnership between patients and researchers is critical in advancing our understanding of rare diseases. Nearly 30 years ago, collaboration began with Caring Matters Now and researchers, leading to significant progress in scientific knowledge about CMN. These collaborations have redefined research priorities to focus not solely on clinical outcomes but also on psychosocial impacts and daily life challenges faced by those living with CMN.
Patient input in defining research priorities ensures that studies address meaningful questions, ultimately benefiting the wider community. Initiatives like the OCOMEN project demonstrate how the integration of patient knowledge can lead to more relevant and effective research outcomes.
The landscape for CMN research and care has evolved dramatically, characterized by improved clinical understanding and stronger international networks. However, the core takeaway extends beyond CMN to all rare diseases: research should fundamentally be informed by those it aims to help. The message for clinicians and researchers is clear: each data point represents a person, and every research question stems from real-life experiences. Incorporating the insights and expertise of patients is essential in driving scientific discovery and improving the overall quality of life for individuals living with rare conditions. This partnership ensures that progress in medicine not only enhances health outcomes but also nurtures personal identity and community integration.